Benjamin Brady
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- Cutaneous Melanoma Detection and Management 6
-
- Melanoma and MAPK Pathways 4
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- William Allen Robinson (4 shared papers)Peter Gibbs (2 shared papers)Richard F. Kefford (2 shared papers)Peter Hersey (1 shared paper)Adele Morganti (1 shared paper)Philip R. Clingan (1 shared paper)Leonard Michael Glodé (1 shared paper)Lin Qi (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Translational Medicine (2 papers)New England Journal of Medicine (1 paper)Melanoma Research (1 paper)Molecular Cancer (1 paper)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Benjamin Brady
18 papers receiving 5.9k citations
Benjamin Brady's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 4.5k
- Immunology 307
- Cancer Research 195
- Molecular Biology 786
- Pulmonary and Respiratory Medicine 321
Countries citing papers authored by Benjamin Brady
This map shows the geographic impact of Benjamin Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Brady more than expected).
Fields of papers citing papers by Benjamin Brady
This network shows the impact of papers produced by Benjamin Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Brady. The network helps show where Benjamin Brady may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Brady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab in Previously Untreated Melanoma without BRAF Mutation Hit paper breakdown → | 2014 | 4689 |
| 2 | Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis Hit paper breakdown → | 2017 | 500 |
| 3 | 2018 | 286 | |
| 4 | 2020 | 184 | |
| 5 | 2017 | 96 | |
| 6 | 2018 | 52 | |
| 7 | 2010 | 49 | |
| 8 | 2015 | 49 | |
| 9 | Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors. | 2004 | 28 |
| 10 | 2001 | 24 | |
| 11 | 2016 | 24 | |
| 12 | 2016 | 21 | |
| 13 | 2002 | 18 | |
| 14 | 2018 | 11 | |
| 15 | 2003 | 9 | |
| 16 | 2016 | 9 | |
| 17 | 2016 | 5 | |
| 18 | 1998 | 1 |
About Benjamin Brady
Benjamin Brady is a scholar working on Oncology, Molecular Biology, Public Health, Environmental and Occupational Health, Cancer Research and Rheumatology, having authored 18 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (4 papers), Palliative Care and End-of-Life Issues (2 papers), Autoimmune and Inflammatory Disorders (1 paper), Palliative and Oncologic Care (1 paper), Cancer Genomics and Diagnostics (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Oncology (4.5k citations), Immunology (307 citations), Cancer Research (195 citations), Molecular Biology (786 citations) and Pulmonary and Respiratory Medicine (321 citations). Benjamin Brady has collaborated with scholars based in Australia, United States and France. Frequent co-authors include William Allen Robinson, Peter Gibbs, Richard F. Kefford, Peter Hersey, Adele Morganti, Philip R. Clingan, Leonard Michael Glodé, Lin Qi, Rene C. Gonzalez and Grant A. McArthur. Their work appears in journals such as Journal of Clinical Oncology, Journal of Translational Medicine, New England Journal of Medicine, Melanoma Research and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.